

The Quidel Triage BNP Test is a rapid, point-of-care fluorescence immunoassay used with the Quidel Triage MeterPro®. The test is used to measure B-type natriuretic peptide (BNP) in EDTA anticoagulated whole blood or plasma specimens. The Quidel Triage BNP Test is the first rapid BNP immunoassay indicated for risk stratification for both acute coronary syndrome and heart failure.
References
Quidel Triage BNP [Package Insert]. San Diego, CA: Alere, Inc.; 2015.
Maisel AS, et al., “Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure”. N Engl J Med 2002; 347: 161−8.
Cowie MR, et al., “Recommendations on the clinical use of B-type Natriuretic Peptide testing (BNP or NTproBNP) in the UK and Ireland”, The British Journal of Cardiology 2010; 17:76-80.
Features & Benefits
Benefit |
---|
Aid in the diagnosis of CHF |
Aid in the assessment of severity of CHF |
Risk stratify patients with ACS |
Risk stratify patients with HF |
Allows immediate consultation with patients on test results |
Improves clinical, economic and operational outcomes |
Product Specifications
Product Spec Name | Product Spec Data |
---|---|
Sample type | Plasma or whole blood in EDTA |
Time to results | Yields results in about 15 minutes |
CLIA complexity | Waived for whole blood |
Ordering Information
Catalog Number | Description |
---|---|
98000XR | Quidel Triage BNP Test |
98000XREU (Worldwide) | Quidel Triage BNP Test |
98013XR (Worldwide) | Quidel Triage BNP Control 1 |
98014XR (Worldwide) | Quidel Triage BNP Control 2 |
98015XR (Worldwide) | Quidel Triage BNP Calibration Verification |
88753 (Worldwide) | Quidel Triage Total 5 Control 1 |
88754 (Worldwide) | Quidel Triage Total 5 Control 2 |
88755 (Worldwide) | Quidel Triage Total 5 Calibration Verification |